1. Report Overview

1.1 Global Precision Medicine Market Overview

1.1.1 Precision Medicine Market – Segmentation by Technology

1.1.2 Precision Medicine Market – Segmentation by Ecosystem Players

1.1.3 Precision Medicine Market – Segmentation by Therapeutic Application

1.1.4 Precision Medicine Market – Segmentation by Geography

1.2 Why You Should Read This Report

1.3 How This Report Delivers

1.4 Key Questions Answered by This Analytical Report Include

1.5 Who is This Report For?

1.6 Methodology

1.6.1 Primary Research

1.6.2 Secondary Research

1.6.3 Market Evaluation & Forecasting Methodology

1.7 Frequently Asked Questions (FAQ)

1.8 Associated Visiongain Reports

1.9 About Visiongain

2. Introduction to Precision Medicine

2.1 Evolution and Brief History of Precision Medicine

2.2 Key Benefits of Precision Medicine

2.3 Precision Medicine: Key Areas of Application

2.4 Precision Medicine: Key Elements

2.5 Precision Medicine: Different Type of Data Used by Big Data Companies

2.6 Precision Medicine: Area of Interest

3. Global Precision Medicine Market 2018-2028

3.1 Global Precision Medicine Market by Ecosystem, 2018-2028

3.2 Global Precision Medicine Market by Technology, 2018-2028

3.3 Global Precision Medicine Market by Therapeutic Application, 2018-2028

3.4 Global Precision Medicine Market by Geography, 2018-2028

4. Market Dynamics

4.1 Global Precision Medicine Market Drivers

4.1.1 Upcoming Technologies in Healthcare

4.1.2 Collaboration of Big Data Companies with Pharma & Biotech Companies

4.1.3 Greater Involvement in Personal Healthcare

4.1.4 A Rise in Genetic Diseases

4.1.5 Growing Deamnd for Targeted Therapies

4.2 Global Precision Medicine Market Restraints

4.2.1 Limitations in Application due to Lack of Research and Evidences

4.2.2 Stringent Regulatory Framework and Reimbursement Policies

4.2.3 Stringent Regulations and Standards

4.2.4 Higher Cost of Diagnostic

4.2.5 Risk to Personal Data

4.2.6 Risk of failure of Software or Hardware

4.2.7 Lack of Knowledge and Awareness

4.3 Global Precision Medicine Market Opportunities

4.3.1 Increasing Awareness in Developing Economies

4.3.2 Reduction in the cost of Genome Sequencing

4.4 Regulatory Bodies

4.4.1 Food and Drug Administration (FDA)

4.4.2 Medicines and Healthcare Products Regulatory Agency (MHRA)

4.4.3 Therapeutic Goods Administration (TGA)-Australia

4.4.4 Conformité Européenne (CE)

4.5 Consortiums

4.6 Alliances/Associations

5. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Ecosystem Players

5.1 Introduction

5.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Ecosystem Players

5.2 Global Pharmaceuticals and Biotechnology Companies Submarket Forecast 2018-2028

5.2.1 Key Market Trends, Developments and Participants

5.2.1.1 Market Trends

5.2.1.2 Market Developments

5.2.1.3 Key Participants

5.3 Global Diagnostic Tools Companies Submarket Forecast 2018-2028

5.3.1 Key Market Trends, Developments and Participants

5.3.1.1 Market Trends

5.3.1.2 Market Developments

5.3.1.3 Key Participants

5.4 Global Healthcare IT Specialists/ Big Data Companies Submarket Forecast 2018-2028

5.4.1 Key Market Trends, Developments And Participants

5.4.1.1 Market Trends

5.4.1.2 Market Developments

5.4.1.3 Key Participants

5.5 Global Clinical Laboratories Submarket Forecast 2018-2028

5.5.1 Key Market Trends, Developments And Participants

5.5.1.1 Regulatory bodies and compliances

5.5.1.2 Market Trends

5.5.1.3 Key Participants

6. Global Precision Medicine Market Forecast 2018-2028 - Segmented by Technology

6.1 Introduction

6.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Technology

6.2 Global Companion Diagnostics Submarket Forecast 2018-2028

6.3 Global Biomarker-based Test Submarket Forecast 2018-2028

6.3.1 Role of Biobanking in Biomarker

6.3.2 Key Participants

6.4 Global Targeted Therapeutics Submarket Forecast 2018-2028

6.4.1 Key Participants

6.5 Global Pharmacogenomics Submarket Forecast 2018-2028

6.5.1 Key Market Trends, Developments And Participants

6.5.1.1 Market Trends

6.5.1.2 Market Developments

6.5.1.3 Key Participants

6.6 Global Molecular Diagnostics Submarket Forecast 2018-2028

6.7 Global Other Technology Submarket Forecast 2018-2028

6.8 Next-Generation Sequencing

6.9 Consumer Genomics

6.10 3D Printing

6.11 Prosthetics Market

6.12 Human Tissues Market

7. Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application

7.1 Introduction

7.1.1 Global Precision Medicine Market Forecast 2018-2028: Segmented by Therapeutic Application

7.2 Global Cancer Submarket Forecast 2018-2028

7.2.1 Types of cancer

7.2.2 Key Market Trends, Developments & Participants

7.2.2.1 Market Trends

7.2.2.2 Market Developments

7.2.2.3 Key Participants

7.3 Global Cardiovascular Disease (CVD) Submarket Forecast 2018-2028

7.3.1 Drugs & Tests

7.3.2 Market Trends & Market Developments

7.3.2.1 Market trend

7.3.2.2 Market Developments

7.3.2.3 Key Participants

7.4 Global Central Nervous System Market Forecast 2018-2028

7.4.1 Neurological

7.4.1.1 Neurological Drugs & Tests

7.4.2 Psychiatric Disorders

7.4.2.1 Psychiatric Disorder Drugs & Tests

7.4.3 Market tends & Market Developments

7.4.3.1 Market Trends

7.4.3.2 Key Participants

7.5 Global Infectious Diseases Submarket Forecast 2018-2028

7.5.1 Infectious Diseases Drugs & Tests

7.5.2 Market Developments & participants

7.5.2.1 Key Developments

7.5.2.2 Key Participants

7.6 Global Other Therapeutic Application Submarket Forecast 2018-2028

7.6.2 Market trends, Developments & Participants

7.6.2.1 Market Trends

7.6.2.2 Key Developments

7.6.2.3 Key Participants

8. Global Precision Medicine Market Forecast 2018-2028 – Segmented by Geography

8.1 Introduction

8.2 The Americas Precision Medicine Market Forecast 2018-2028

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.1.3 Key Market Trends, Developments and Participants

8.2.1.3.1 Regulations and Compliances

8.2.1.3.2 Market Trends

8.2.1.3.3 Market Developments

8.2.1.4 Key Participants

8.2.2 South America

8.2.2.1 Key Market Trends, Developments and Participants

8.2.2.1.1 Regulations and Compliances

8.2.2.1.2 Market Trends

8.2.2.2 Key Participants

8.3 Europe Precision Medicine Market Forecast 2018-2028

8.3.1 Key Market Trends, Developments And Participants

8.3.1.1 Regulations and Compliances

8.3.1.2 Market Developments

8.3.1.3 Key Participants

8.4 Asia-Pacific (APAC) Precision Medicine Market Forecast 2018-2028

8.4.1 Key Market Trends, Developments and Participants

8.4.1.1 Market Developments

8.4.1.2 Key Participants

8.5 Rest of the World/Midde East & Africa (MEA) Precision Medicine Market Forecast 2018-2028

8.5.3 Key Market Developments And Participants

8.5.3.1 Market Developments

8.5.3.2 Key Participants

9. Market Analysis

9.1 Porter’s Five Forces Analysis

9.1.1 Bargaining Power of Supplier

9.1.2 Bargaining Power of Buyer

9.1.3 Industry Rivalry

9.1.4 Threat of New Entrants

9.1.5 Threat of Substitutes

9.2 Value Chain Analysis

9.2.1 Device Manufacturer & Drug Producers

9.2.2 Healthcare Providers

9.2.3 Healthcare IT Or Big Data Companies

9.2.4 Regulators

9.2.5 Third Party Payers

9.2.6 Patients

10. Company Profiles

10.1 Abbott Laboratories: Overview

10.1.1 Abbott Laboratories: Products & Service

10.1.2 Abbott Laboratories: Key Developments

10.1.3 Abbott Laboratories: Future Outlook and Growth Strategy

10.2 GE Healthcare: Overview

10.2.1 GE Healthcare: Products & Service

10.2.2 GE Healthcare: Key Developments

10.2.3 GE Healthcare: Future Outlook and Growth Strategy

10.3 GlaxoSmithKline plc: Overview

10.3.1 GlaxoSmithKline plc: Products & Service

10.3.2 GlaxoSmithKline plc: Future Outlook and Growth Strategy

10.4 Johnson & Johnson: Overview

10.4.1 Johnson & Johnson: Products & Service

10.4.2 Johnson & Johnson: Key Developments

10.4.3 Johnson & Johnson: Future Outlook and Growth Strategy

10.5 Pfizer Inc.: Overview

10.5.1 Pfizer Inc.: Products & Service

10.5.2 Pfizer Inc.: Key Developments

10.5.3 Pfizer Inc.: Future Outlook and Growth Strategy

10.6 Laboratory Corporation of America Holdings Overview

10.6.1 Laboratory Corporation of America Holdings: Products & Service

10.6.2 Laboratory Corporation of America Holdings: Key Developments

10.7 Danaher Corporation: Overview

10.7.1 Danaher Corporation: Products & Service

10.7.2 Danaher Corporation: Key Developments

10.7.3 Danaher Corporation: Future Outlook and Growth Strategy

11. Competitive Landscape

11.1 Introduction

11.1.1 Partnerships, Collaborations and Joint Ventures

11.1.2 Product Launch/Development

11.1.3 Acquisitions

11.1.4 Expansion

11.1.5 Patents, Approvals and Certifications

11.1.6 Others

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Tables

Table 2.1 Key Benefits of Precision Medicine

Table 2.2 Key Elements of Precision Medicine

Table 4.1 Key Benefits of Precision Medicine for Patients

Table 4.2 Key Laws & Regulatory Bodies in the Precision Medicine Industry

Table 4.3 Key Consortiums in the Precision Medicine Industry

Table 4.4 Key Alliances/Associations in the Precision Medicine Industry

Table 5.1 Global Precision Medicine Market Forecast by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.2 Global Pharma & Biotech Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.3 Global Pharma & Biotech Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.4 Global Pharma & Biotech Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.5 Key Developments In Pharma & Biotech Companies

Table 5.6 Global Diagnostic Tool Companies Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.7 Global Diagnostic Tool Companies Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.8 Global Diagnostic Tool Companies Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.9 Key Developments In Diagnostic Companies

Table 5.10 Global Healthcare ITs/Big Data Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)

Table 5.11 Global Healthcare ITs/Big Data Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)

Table 5.12 Global Healthcare ITs/Big Data Submarket by Geography: Revenue ($m), AGR (%), CAGR (%)

Table 5.13 Key Developments In Healthcare IT/Big Data Companies

Table 5.14 Clinical Laboratories: Global Precision Medicine Market Value by Sub-Market Types: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.15 Clinical Laboratories: Global Precision Medicine Market Value by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%)

Table 5.16 Clinical Laboratories: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.1 Global Precision Medicine Market by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.2 Global Companion Diagnostics Subamarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.3 Global Companion Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.4 List Of Approved Companion Diagnostic Devices

Table 6.5 Global Biomarker-based Test Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.6 Global Biomarker-based Test Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.7 List of Biobanks

Table 6.8 Examples Of Biobanking Initiatives Across Selected OECD Countries

Table 6.9 Global Targeted Therapeutic Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.10 Global Targeted Therapeutic Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.11 Global Pharmacogenomics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.12 Global Pharmacogenomics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.13 Market Developments

Table 6.14 Global Molecular Diagnostics Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.15 Global Molecular Diagnostics Submarket by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.16 Some Examples of Human Genetic Tests That Have Been Approved by the FDA

Table 6.17 Some Examples of Microbial Tests That Have Been Approved by the FDA

Table 6.18 Global Others Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 6.19 Global Others Submarket Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.1 Global Precision Medicine Market by Therapeutic Application: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.2 Global Cancer Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.3 Global Cancer Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.4 Global Cancer Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.5 Precision Medicine Drugs And Relevant Genes: Oncology

Table 7.6 Precision Medicine Genetic Tests With Respect To Oncology

Table 7.7 Key Developments

Table 7.8 Global Cardiovascular Diseases Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.9 Global Cardiovascular Diseases Submarket by Technology: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.10 Global Cardiovascular Diseases Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.11 Precision Medicine Drugs And Relevant Genes: Cardiovascular

Table 7.12 Precision Medicine Genetic Tests With Respect to Cardiovascular

Table 7.13 Key Developments

Table 7.14 Global CNS Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.15 Global CNS Submarket by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.16 CNS: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.17 Precision Medicine Drugs And Relevant Genes: Neurology

Table 7.18 Precision Medicine Drugs And Relevantgenes: Psychiatric Disorders

Table 7.19 Precision Medicine Genetic Tests With Respect to Psychiatric Disorders

Table 7.20 Psychiatric Disorders: Key Developments

Table 7.21 Global Infectious Disease Submarket by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%)

Table 7.22 Global Infectious Disease Submarket by Technology: Revenue ($m), AGR (%), CAGR (%)

Table 7.23 Global Infectious Disease Submarket by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.24 Precision Medicine Drugs and Relevant Genes: Infectious Diseases

Table 7.25 Key Developments

Table 7.26 Global Other Therapeutic Application by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.27 Global Other Therapeutic Application by Technology: Revenue ($m), AGR (%), CAGR (%) 2017-2028

Table 7.28 Other Therapeutics: Global Precision Medicine Market Value by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.29 Precision Medicine Drugs And Relevant Genes: Other Diseases

Table 7.30 Precision Medicine Genetic Tests With Respect To Other Diseases

Table 7.31 Key Developments

Table 8.1 Global Precision Medicine Market by Geography: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.2 Americas Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.3 Americas Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.4 Market Developments

Table 8.5 Europe Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.6 Europe Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.7 Market Developments

Table 8.8 APAC Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.9 APAC Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.10 Market Developments

Table 8.11 ROW Precision Medicine Market by Ecosystem Players: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.12 ROW Precision Medicine Market by Therapeutic Applications: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.13 Market Developments

Table 9.1 Key Factors Affecting the Bargaining Power of Suppliers

Table 9.2 Key Factors Affecting the Bargaining Power of Buyer

Table 9.3 Key Factors Affecting the Industry Rivalry

Table 9.4 Key Factors Affecting the Threat of New Entrants

Table 9.5 Key Factors Affecting the Threat of Substitutes

Table 10.1 Abbott Laboratories Overview

Table 10.2 Abbott Laboratories: 5-year Revenue, Net Income, Operating Income

Table 10.3 Abbott Laboratories : Key Developments

Table 10.4 GE Healthcare Overview

Table 10.5 GE Healthcare: 5-year Revenue, Profit

Table 10.6 GE Healthcare: Key Developments

Table 10.7 GlaxoSmithKline plc: Overview

Table 10.8 GlaxoSmithKline plc: 5-year Revenue, Operating Profit, Profit After Tax)

Table 10.7 Johnson & Johnson: Overview

Table 10.8 Johnson & Johnson: 5-year Revenue, Net Earnings

Table 10.9 Johnson & Johnson: Key Developments

Table 10.10 Pfizer Inc. Overview

Table 10.11 Pfizer Inc.: 5-year Revenue, Net Income, Operating Income

Table 10.12 Pfizer Inc: Key Developments

Table 10.13 Laboratory Corporation of America Holdings: Overview

Table 10.14 Laboratory Corporation of America Holdings: 5-year Revenue, Net Income, Operating Income

Table 10.15 Laboratory Corporation: Key Developments

Table 10.16 Danaher Corporation: Overview

Table 10.17 Danaher Corporation: 5-year Revenue, Net Income, Operating Profit

Table 10.18 Danaher Corporation: Key Developments

Table 11.1 Key Partnerships, Collaborations and Joint Ventures

Table 11.2 Key Product Developments

Table 11.3 Key Acquistions

Table 11.4 Key Expansion

Table 11.5 Key Patents, Approvals And Certifications

Table 11.6 Key Other Events

List of Figures

Figure 1.1 Global Precision Medicine Market – Segmentation by Technology

Figure 1.2 Global Precision Medicine Market – Segmentation by Ecosystem

Figure 1.3 Global Precision Medicine Market - Segmentation by Therapeutic Application

Figure 1.4 Global Precision Medicine Market - Segmentation by Geography

Figure 2.1 History of Precision Medicine

Figure 2.2 Key Areas of Application of Precision Medicine

Figure 2.3 Key Different Type of Data Used by Big Data Companies in Precision Medicine

Figure 2.4 Key Areas of Interest of Precision Medicine

Figure 3.1 Global Precision Medicine Market Share by Ecosystem: Revenue ($bn), 2017-2028

Figure 3.2 Global Precision Medicine Market Size by Technology: Revenue ($bn), 2017-2028

Figure 3.3 Global Precision Medicine Market Size by Therapeutic Application: Revenue ($bn), 2017-2028

Figure 3.4 Global Precision Medicine Market Size by Geography: Revenue ($bn), 2017-2028

Figure 4.1 Key Difficulties Faced by Players of Precision Medicine Market due to Regulations and Standards

Figure 4.2 FDA’s Role in Precision Medicine

Figure 5.1 Global Precision Medicine Market by Ecosystem Players

Figure 5.2 Role Of Pharmaceuticals And Biotech Companies

Figure 5.3 Challenges Faced by Pharma & Biotech Companies

Figure 5.4 Diagnostic Tests Benefits for Stakeholders

Figure 5.5 Challenges Faced by Diagnostic Companies

Figure 5.6 Benefits Of Big Data

Figure 5.7 Transformation Of Medicine

Figure 5.8 Basic Ingredients Provided by Big Data For Precision Medicine

Figure 5.9 Challenges Faced by Big Data Companies

Figure 5.10 OECD Recommendations On The Governance Of Clinical Trials

Figure 6.1 Types Of Precision Medicine Sub-Market

Figure 6.2 Benefits of Companion Diagnostics

Figure 6.3 Function Of Biomarkers

Figure 6.4 Biobanks Services

Figure 6.5 Development In PGx

Figure 6.6 Model Systems Used In PGx

Figure 6.7 Challenges Of PGx Studies

Figure 6.8 Type of Molecular Diagnostics Test

Figure 6.9 Molecular Diagnostics: Application

Figure 6.10 Molecular Diagnostics: Benefits

Figure 7.1 Global Precision Medicine Market by Therapeutics

Figure 8.1 Global Precision Medicine Market Classification by Geography

Figure 8.2 Key Drivers For Precision Medicine: North America

Figure 8.3 Objectives of the Precision Medicine Initiative

Figure 8.4 APAC: Market Challenges

Figure 9.1 Precision Medicine Market Porter’s Five Forces Analysis, 2017

Figure 9.2 Precision Medicine Market Value Chain

Figure 10.1 Abbott Laboratories: Sales by Business Segment (%), 2017

Figure 10.2 Abbott Laboratories: Sales by Region (%), 2017

Figure 10.3 GE Healthcare: Sales by Business Segment (%), 2017

Figure 10.4 GE Healthcare: Sales by Geography (%), 2017

Figure 10.5 GlaxoSmithKline plc: Sales by Business

Figure 10.6 GlaxoSmithKline plc: Sales by Region (%), 2017

Figure 10.7 Johnson & Johnson: Sales by Business Segment (%), 2017

Figure 10.8 Johnson & Johnson: Sales by Region (%), 2017

Figure 10.9 Pfizer Inc.: Sales by Business Segment (%), 2017

Figure 10.10 Pfizer Inc.: Sales by Region (%), 2017

Figure 10.11 Laboratory Corporation of America Holdings: Sales by Business Segment (%), 2017

Figure 10.12 Laboratory Corporation of America Holdings: Sales by Region (%), 2017

Figure 10.13 Danaher Corporation: Sales by Business Segment (%), 2017

Figure 10.14 Danaher Corporation: Sales by Region (%), 2017

Figure 11.1 Precision Medicine Market Key Development Strategies